Dr. Cheorl-Ho Kim has been recognized as a pioneer expert in Molecular Hepatology, Glycobiology and Glycomics study, as evidenced and demonstrated by the following confirmations: The Lab has the authors of over 300 peer-reviewed articles published in international scientific journals. His distinguished discoveries recognized in the biomedical area are well documented in the Academic Society from the following outstanding findings: Hepatic B Viral hepatocarcinoma and PTEN (Cancer Research 2003), asialo-1 acid glycoprotein in liver cirrhosis and carcinoma (Hepatology Research, 2003), UDP-N-GlcNAc:β-D-Man-1,4-N-GlcNAc-T-III in hepatitis (Glycoconjugate J, 2003), plasma MMP-9/2 and α-fetoproteins in HBV chronic hepatitis (J. Gastroenterol. and Hepatology. 2004), HBV metastatic potential (FASEB J. 2004), Hepatic V and GnT-III-Apolipoprotein B (JBC. 2004), Disialo GD3 in VSMC responses (JBC. 2004), therapeutic hepatocarcinoma cells (FASEB J. 2004), Transglutaminase 2 signaling in leukemia (FEBS Lett. 2004), bisecting N-GlcNAc-T-III in HBV (J Gastroenterol Hepatol, 2004), Monosialyl GM3 in leukemic differentiation (Glycobiology 2005), MMP-9 in In Vitro Fertilization (British J Obstetrics and Gynecology 2005), disialo GD3 Fas-induced T cells (Glycobiology 2006), GM3 in PTEN-mediated progression (Glycobiology 2006), ROS in sialic GD3-cell function (FASEB J 2006), AP-2a in GM3-PTEN (Glycobiology 2008), sialidase in leukemia (Biochimica et Biophysica Acta 2008), GM3-VEGFR-2 interaction (Glycobiology 2009), GD3 in breast cancer cells (Biological Chemistry 2009), pig CMAH and N-glycolylneuraminic acid (Biochemical J 2010), pST6GalNAc IV for Neu5Acalpha2-3Galbeta1-3GalNAc (Glycoconjugate J 2011), GM3 in TGF-β1-induced EMT (Biochemical J. 2013), VEGFR-2 in neovascularization (J Molecular Medicine 2013), monosialyl GMs and TGF.receptor interaction (Int. J. of Biochem. Cell Biol. 2014), Sialyl Leuis A/X preference of HBx (Molecular Cancer 2014).
Dr. Cheorl-Ho Kim's research interest interest includes Molecular and Cellular Glycobiology, Hepatic viral carcinogenesis, Membrane Glycolipidomics, Sialoglycobiology, Pathogen-Host interaction.
